Data is not available at this time.
Neutech Group Limited operates as a specialized education and healthcare services provider in China, leveraging a dual-segment approach to drive revenue. The company's core Education Business segment generates income through formal higher education programs, including bachelor's degrees and junior college diplomas, supplemented by educational resources and apprenticeship initiatives. This segment benefits from China's growing demand for digital talent development, positioning Neutech within the competitive private education sector that serves both traditional students and lifelong learners seeking professional upskilling. The Healthcare and Wellness Business segment diversifies revenue streams through medical services, wellness offerings, and medical device sales, creating synergies with educational operations while tapping into China's expanding healthcare market. This integrated approach allows Neutech to maintain a distinctive market position by combining education with practical healthcare applications, though it operates in regulated sectors subject to policy changes. The company's university operations provide stable enrollment-based income while its medical services offer additional growth channels in complementary service sectors.
Neutech generated HKD 2.04 billion in revenue for FY2024 with strong profitability, achieving net income of HKD 465.6 million representing a 22.8% net margin. The company demonstrated solid cash generation with operating cash flow of HKD 702.4 million, significantly exceeding capital expenditures of HKD 244.4 million, indicating efficient conversion of earnings into operational liquidity.
The company exhibits robust earnings power with diluted EPS of HKD 0.72, supported by its dual-segment revenue model. Operating cash flow coverage of capital expenditures at approximately 2.9 times reflects effective capital deployment, though the education sector typically requires ongoing investment in facilities and educational technology to maintain competitive positioning.
Neutech maintains a strong liquidity position with HKD 1.66 billion in cash and equivalents, providing substantial financial flexibility. However, total debt of HKD 3.14 billion indicates leveraged operations, which is common in education infrastructure development, requiring careful monitoring of debt service capabilities given the capital-intensive nature of educational and healthcare facilities.
The company demonstrates shareholder returns through a dividend per share of HKD 0.388, representing a payout ratio of approximately 54% based on EPS. This dividend policy suggests management's confidence in sustainable earnings while retaining capital for growth initiatives in both education and healthcare segments within China's evolving regulatory environment.
With a market capitalization of HKD 1.78 billion, the company trades at approximately 0.87 times revenue and 3.8 times net income. The low beta of 0.259 indicates relative stability compared to broader market movements, reflecting investor perception of defensive characteristics in education and healthcare services.
Neutech's integrated education-healthcare model provides diversification benefits and cross-segment synergies. The company's established university operations and healthcare services position it to benefit from China's ongoing emphasis on digital talent development and healthcare modernization, though regulatory changes in both sectors require careful navigation and adaptive strategy implementation.
Company annual reportHong Kong Stock Exchange filingsCompany description and financial data provided
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |